US 12364775
Viral vectors for cancer therapy
granted A61KA61K35/763A61K38/193
Quick answer
US patent 12364775 (Viral vectors for cancer therapy) held by Krystal Biotech, Inc. expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Krystal Biotech, Inc.
- Grant date
- Tue Jul 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 32
- CPC classes
- A61K, A61K35/763, A61K38/193, A61K38/2013, A61K38/208